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ABSTRACT 
Background: Intravenous bolus dose of lignocaine is generally used to reduce haemodynamic changes associated 
with intubation and extubation. Whereas lignocaine intravenous infusion has been used for post‑ operative 
analgesia. 
Aims and Objectives: To evaluate the effect of peri-operative intravenous infusion of lignocaine on hemodynamic 
responses to intubation, extubation and post-operative analgesia. Materials and Methods:80 patients undergoing 
elective laparoscopic cholecystectomy were included in our study and they were randomly divided into two groups, 
Group A and B of 40 each. Group A patients received 6 ml normal saline as bolus over 10 minutes followed by 6 
ml/hour infusion, whereas in Group B, patients received preservative free 2% lignocaine 1.5 mg/kg IV bolus (made 
to a volume of 6 ml with normal saline) administered over a period of 10 minutes and thereafter an infusion at a rate 
of 1.5 mg/kg/hour (pre‑ diluted in normal saline made to a volume of 6 ml/hour. P < 0.05 was considered as 
significant. Results: Group B patients showed significantly longer mean pain‑ free post‑ operative period and also a 
less rise in pulse rate and mean arterial pressure compared to the Group A (P < 0.05) during intubation and 
extubation. Conclusion: Lignocaine infusion can successfully avert the change of haemodynamics resulting from 
intubation and extubation.  
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Introduction 
 
 
Tracheal intubation and succeeding extubation causes 
haemodynamic changes like rise in pulse rate, arterial 
blood pressure, arrhythmia, and rise of intracranial and 
intraocular pressure[1].To control these changes many 
drugs have been prescribed like lignocaine, esmolol, 
alfentanil and fentany[1-3].In tracheal intubation and 
extubation, bolus administration of lignocaine is 
extremely effectual, which has been used to minimise 
haemodynamic changes. Anaesthetists usually use 
intravenous infusion of lignocaine in perioperative 
period to control postoperative pain. Even though  
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laparoscopic cholecystectomy is a minimally invasive 
surgery, a lot of patients still experience moderate to 
severe pain after operation. In such patients, lignocaine 
can help to decrease pain[4-6]. 
We carried out our study to examine whether the 
intravenous injection of lignocaine in perioperative 
period followed by the intravenous infusion of 
lignocaine during operation may lessen haemodynamic 
changes at tracheal intubation and extubation and also 
whether this relieves postoperative pain after elective 
laparoscopic cholecystectomy. 
 
Materials and Methods 
 
We carried our study in 80 patients undergoing elective 
laparoscopic cholecystectomy from December 2015 to 
November 2016, after obtaining institutional ethical 
committee approval. Consent was obtained from all the 
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patients. Initially 96 patients were enrolled in the study. 
16 patients were excluded as they did not meet the 
inclusion criteria. 80 patients were divided randomly 
into two groups of 40 each.  
We followed the methodology used by Jain et al 
(2015). 
Group A patients (n=40): Received 6 ml normal 
saline as bolus over 10 minutes, followed by 6 ml/hour 
infusion and 
Group B patients (n=40): Received preservative free 
2% lignocaine 1.5 mg/kg IV bolus (made to a volume 
of 6 ml with normal saline) administered over a period 
of 10 minutes and thereafter an infusion at a rate of 1.5 
mg/kg/hour (pre‑ diluted in normal saline made to a 
volume of 6 ml/hour. 
Inclusion Criteria 
1. Patients undergoing elective laparoscopic 
cholecystectomy, 
2. Patients without  any  history of malignancies, 
3. Patients not allergic to the study drugs.  
Exclusion Criteria 
1. Patients with cardio‑ respiratory problems 
2. Patients with renal, hepatic or endocrine disease, 
3. Whenever the surgical procedure necessitated the 
conversion of laparoscopic to open 
cholecystectomy,  
4. Whenever the surgical time exceeded 180 minutes. 
All the subjects were informed about Numeric pain 
Rating Scale (NRS), with 0 as ‘no pain’ and 10 as 
‘worst imaginable pain’. The patients were asked to 
inform about any post‑ operative symptoms like light 
headedness, metallic taste, sedation, nausea and 
vomiting.  
 A team consisted of a surgeon and anaesthetist 
carried out surgeries. Keeping in mind about the 
potential lignocaine toxicity, the maximum time of 
infusion was kept to 180 minutes. All the patients were 
pre‑ medicated with injection midazolam 0.025 mg/kg 
IV, injection ketorolac 0.5 mg/kg intramuscular (IM) 
(maximum of 30 mg) and injection ondansetron 0.1 
mg/kg IV. Patients were induced with 2 mg/kg of IV 
propofol and relaxed with 0.1 mg/kg of vecuronium 
bromide and trachea intubated. Anaesthesia was 
maintained with a mixture of 40% oxygen and 60 % 
nitrous oxide and an infusion of propofol in step down 
manner. The propofol infusion and nitrous oxide were 
stopped at the conclusion of the surgery. After reversal 
of residual neuromuscular blockade with a mixture of 
neostigmine and glycopyrrolate, patient’s trachea was 
extubated.  
Then the patients were shifted to the recovery room. 
The numeric pain scale was recorded every 15 minutes 
in the initial first hour and then every 2 hour or 
whenever patient complained of pain.  
Haemodynamic changes were assessed using Pulse 
Rate (PR) and Mean Arterial Pressure (MAP) while 
post‑ operative analgesia was assessed by recording 
pain‑ free period. Any other complications were 
recorded. PR, systolic and diastolic BP were 
notedimmediately prior to starting lignocaine infusion, 
prior to induction of anaesthesia, post‑ induction, after 
tracheal intubation, and subsequently at 3, 5, 10 
minutes after intubation. Likewise, they were also 
recorded immediately prior to the administration of 
reversal agent, post‑ extubation, and subsequently at 3, 
5, 10 minutes after tracheal extubation. Pain‑ free 
period (NRS <4) was taken as period from the 
conclusion of surgery to the first requirement of 
injection ketorolac. The records of patients were 
reviewed at the end of 24 hour to note the total amount 
of ketorolac and pentazocine injections administered. 
The data was analysed by SPSS for windows (version 
17) statistical package (SPSS Inc., Chicago, IL). The 
data were expressed as mean ± standard deviation 
(SD). 
 
 
Results 
Mean age, weight, and duration of surgery in Group A (34.53 years, 51.77 kg, and 53.37 min, respectively) were 
comparable to Group B (34.97 years, 53.90 kg, and 54.80 min, respectively) [Table 1 and Graph 1]. 
 
Table 1: Demographics of patients in both groups 
 
Variables Group A  Group B P value 
Age (years) 36.82±9.51 35.96±10.92 0.7082 
Weight (Kg) 54.00±10.11 55.12±9.01 0.6024  
Duration of Surgery (Minutes) 51.18±8.27 52.60±9.32 0.4732  
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Graph 1: Demographics of patients in both groups 
 
 
 Haemodynamic parameters increased significantly in both the groups, but was significantly less in group B 
than Group A. In the same way, during extubation, both PR and MAP increased significantly in both the groups 
when compared to the immediate pre‑ reversal values within the same group. However, the increase in values of 
both the parameters in Group B was significantly less compared to those in Group A [Tables 2 and 3]. 
 
Table 2: Changes in Pulse rate of both groups 
 
Time of Observation Group A (Minutes) Group B (Minutes) P value 
Before infusion of drug 89.91±14.67 83.40±13.39 <0.0001*  
Before induction 89.19±11.09  83.93±12.89 0.054 
Post-induction 88.12±9.30 81.68±11.34 0.0069*  
Post-intubation immediate 112.48±12.31 101.24±11.58  <0.0001*  
Post-intubation 3 minutes 92.64±12.35  84.27±12.31 <0.0001*  
Post-intubation 5 minutes 91.89±21.85  81.98±11.37 <0.0001*  
Post-intubation 10 minutes 84.25±13.68  78.91±10.93 0.0574 
Prior to reversal 89.68±11.56  82.86±13.68 <0.0001*  
Post-extubation immediate 114.64±15.98 105.92±11.25 0.0061 
Post- extubation 3 minutes 98.64±13.57  94.96±11.96 0.2020  
Post-extubation 5 minutes 93.12±13.83  91.45±10.89  0.5502  
Post-extubation 10 minutes 86.89±13.68  82.56±11.86  0.1344  
* - Statistically Significant 
 
Table 3: Changes in MAP of both groups 
 
Time of Observation Group A (Minutes) Group B (Minutes) P value 
Before infusion of drug 96.81±7.69  93.24±6.81 <0.0001*  
Before induction 95.68±6.85 92.43±6.13 <0.0001*  
Post-induction 78.26±8.01 81.91±8.23 <0.0001*  
Post-intubation immediate 121.42±10.25 109.61±4.52 <0.0001* 
Post-intubation 3 minutes 104.95±7.94  95.47±6.28 <0.0001* 
Post-intubation 5 minutes 102.78±6.89 93.84±6.62 <0.0001* 
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Post-intubation 10 minutes 95.87±7.79  94.29±5.74 0.3049  
Prior to reversal 104.68±6.14  94.99±5.98 <0.0001* 
Post-extubation immediate 121.42±10.34  109.93±6.03 <0.0001* 
Post- extubation 3 minutes 108.12±6.87 98.96±5.18 <0.0001* 
Post-extubation 5 minutes 102.23±8.17  98.13±6.32 0.0141  
Post-extubation 10 minutes 98.87±6.23  97.01±7.93 0.247 
* - Statistically Significant 
 
The mean pain‑ free period was less than an hour in Group A, while it was approximately 5 hours in Group B. In 
the post‑ operative period, the need of injection ketorolac was 63.58 mg in Group A and 25.71 mg in Group B in 24 
hour. Whereas the  need of pentazocine, as a rescue analgesic, was 13.31 mg in Group A and 7.14 mg in Group B 
[Table 4 and Graph 2]. 
 
 
Table 4: Comparison of analgesic requirement of both the groups in 24 hours 
 
Parameter  Group A  Group B  P value 
Pain-free period (NRS <4) (minutes) 51.65±98.65 309.13±356.28 <0.0001* 
Ketorolac requirement (mg) 63.58±16.97 25.71 ±15.86 <0.0001* 
Pentazocine requirement (mg) 13.31±9.12 7.14 ±6.96 <0.0001* 
NRS – Numeric pain rating scale 
 
Graph 2: Comparison of analgesic requirement of both the groups in 24 hour 
 
 
 Regarding side effects four patients in the Group B complained of drowsiness in the post‑ operative period 
lasting between 12 and 15 minutes. 
 
Discussion 
 
Studies have shown that lignocaine effectively controls 
haemodynamic changes during tracheal intubation and 
extubation and also provides post‑ operative analgesia. 
Hence, we carried out this study to ascertain the 
beneficial effects of lignocaine by evaluating the effect 
of peri-operative intravenous infusion of lignocaine on 
hemodynamic responses to intubation, extubation and 
post-operative analgesia[2-4]. 
We included only those patients who underwent 
laparoscopic cholecystectomy, to prevent any disparity 
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in intensity of haemodynamic changes and 
post‑ operative pain. We included only female patients 
to avoid any gender based bias[1,3]. 
For all the patients, lignocaine dosage was fixed and 
the total duration was restricted to 180 minutes to avoid 
lignocaine toxicity. The dosage given by us was similar 
to studies by Koppert et al and Groudine  et al[7,8].
 
We found significantly less rise in PR and MAP in 
Group B patients when compared to patients in Group 
A. Our findings are in accordance with Reiz et al and 
Wilson et al[9,10].
 
Whereas Kindler et al[11]reported 
significant effect of lignocaine on PR alone and Wilson 
et al on MAP alone[10]. According to them, the 
attenuating effect of lignocaine might be due to its 
action of arteriolar vasodilatation and increasing the 
depth of general anaesthesia. On the other hand Feng et 
al [12] and Lin et al[13]did not find any significant 
attenuating effect of lignocaine on hemodynamic 
parameters.  
We also found that during tracheal extubation there 
was significantly less rise in PR and MAP in the Group 
B patients than Group A. Our findings are similar to 
Nishina et al and Bidwai et al[14,15].According to 
them, the attenuating effect of lignocaine might be due 
to its cough suppressant activity, which could increase 
BP and PR at the time of extubation due to tracheal 
irritation. Nishina et al[14] and Mikawa et al[16]
 
found 
similar effects on hemodynamic changes with 
diltiazem and combination of lignocaine with 
verapamil respectively. 
 We found pain‑ free interval and analgesic 
requirement in the first 24 hour post‑ operatively was 
significantly less in the Group B than Group A. Our 
findings are similar to Wu et al
 
and Koppert et al[7].
 
Whereas Kaba et al[17]and Groudine  et al[8]
 didn’t 
find any significant analgesic effect of lignocaine 
infusion. Studies have shown that lignocaine 
According to McCarthy et al IV lignocaine infusion in 
the peri‑ operative period is safe and results in lower 
pain scores, reduced post‑ operative analgesic 
requirement and decreased intraoperative anaesthetic 
requirement[19]
 
According to them the effects of 
lignocaine might be due to suppression of neuronal 
excitability in dorsal horn neurons, depression of spike 
activity, amplitude, and conduction time in both 
myelinated A and unmyelinated C fibres and also due 
to decrease in neural response to post‑ operative pain 
by blockade or inhibition of nerve conduction. 
 We analyzed the analgesic action of IV 
lignocaine only upto 24 hour post‑ operatively and 
found it to be significant. Whereas Wu et al [18] and 
Groudine  et al[8]analyzed the analgesic action of IV 
lignocaine from 2 to 48 hours post‑ operatively. 
Koppert et al [7] analyzed analgesic effect only on 2nd 
and 3rd postoperative day. This variation in time may 
be due factors like the type of surgery and the amount 
of tissue trauma involved. 
We found 4 patients complained of excessive 
drowsiness in the post‑ operative period, as was 
reported by Koppert et al[7]
 
and Lee et al[4].We 
suggest further such studies with a larger sample and 
including more parameters like time of hospital stay, 
early ambulation, and total cost effectiveness for the 
patient and also on other surgical procedures. 
 
Conclusion 
 
We carried our study in patients undergoing 
laparoscopic cholecystectomy by adminstering 
lignocaine 1.5 mg/kg bolus followed by 1.5 
mg/kg/hour infusion and found a less rise in PR and 
MAP during the peri‑ intubation and peri‑ extubation 
period. We also found an increase in duration of 
pain‑ free period and reduction of the requirement of 
analgesic in the post‑ operative period. 
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